Krystal Biotech (KRYS) News Today $186.90 +4.29 (+2.35%) As of 11:55 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Krystal Biotech (NASDAQ:KRYS) Receives "Overweight" Rating from Cantor FitzgeraldCantor Fitzgerald reissued an "overweight" rating and issued a $215.00 price target on shares of Krystal Biotech in a research report on Thursday.February 21 at 10:44 AM | marketbeat.comKrystal Biotech (NASDAQ:KRYS) Stock Price Up 7.1% on Analyst UpgradeKrystal Biotech (NASDAQ:KRYS) Shares Up 7.1% on Analyst UpgradeFebruary 21 at 10:40 AM | marketbeat.comKrystal Biotech Soars As Q4 Earnings Put Blockbuster Commercialization In FocusFebruary 21 at 9:09 AM | seekingalpha.comChardan Capital Forecasts Strong Price Appreciation for Krystal Biotech (NASDAQ:KRYS) StockChardan Capital upped their price target on Krystal Biotech from $212.00 to $218.00 and gave the company a "buy" rating in a research note on Thursday.February 21 at 8:09 AM | marketbeat.comHC Wainwright Reiterates "Buy" Rating for Krystal Biotech (NASDAQ:KRYS)February 21 at 4:25 AM | americanbankingnews.comVontobel Holding Ltd. Decreases Stake in Krystal Biotech, Inc. (NASDAQ:KRYS)Vontobel Holding Ltd. lessened its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 60.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,984 shares of the company's stock after sellFebruary 21 at 3:23 AM | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Stock Holdings Cut by Allspring Global Investments Holdings LLCAllspring Global Investments Holdings LLC cut its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 73.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 29,777 shares of the company's stock after selling 81,928 sharesFebruary 21 at 3:05 AM | marketbeat.comKrystal Biotech (NASDAQ:KRYS) Trading 7.1% Higher on Analyst UpgradeFebruary 21 at 2:59 AM | americanbankingnews.comA Glimpse Into The Expert Outlook On Krystal Biotech Through 9 AnalystsFebruary 20 at 4:06 PM | benzinga.comKrystal Biotech (NASDAQ:KRYS) Shares Gap Down - What's Next?Krystal Biotech (NASDAQ:KRYS) Shares Gap Down - Here's WhyFebruary 20 at 11:53 AM | marketbeat.comKrystal Biotech (NASDAQ:KRYS) Given "Buy" Rating at HC WainwrightHC Wainwright reissued a "buy" rating and set a $221.00 price objective on shares of Krystal Biotech in a report on Wednesday.February 20 at 11:45 AM | marketbeat.comQ4 2024 Krystal Biotech Inc Earnings CallFebruary 20 at 11:06 AM | finance.yahoo.comKrystal Biotech Inc (KRYS) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...February 20 at 11:06 AM | finance.yahoo.comKrystal Biotech shares rise 20% following earnings callFebruary 20 at 11:06 AM | bizjournals.comKrystal Biotech price target raised to $215 from $206 at CitiFebruary 20 at 11:06 AM | markets.businessinsider.comKrystal Biotech (NASDAQ:KRYS) Posts Quarterly Earnings Results, Beats Estimates By $0.23 EPSKrystal Biotech (NASDAQ:KRYS - Get Free Report) announced its quarterly earnings data on Wednesday. The company reported $1.52 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.29 by $0.23. Krystal Biotech had a net margin of 21.68% and a return on equity of 7.54%.February 20 at 8:59 AM | marketbeat.comTimesSquare Capital Management LLC Acquires 44,646 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)TimesSquare Capital Management LLC lifted its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 39.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 158,868 sharFebruary 20 at 4:46 AM | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Receives Average Recommendation of "Buy" from AnalystsShares of Krystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) have been assigned a consensus rating of "Buy" from the eight brokerages that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, six have given a buy reFebruary 20 at 4:27 AM | marketbeat.comKrystal Biotech projects EU and Japan launches for VYJUVEK in 2025, targeting $1B global peak salesFebruary 19 at 2:40 PM | msn.comKrystal Biotech, Inc. (KRYS) Q4 2024 Earnings Call TranscriptFebruary 19 at 12:02 PM | seekingalpha.comKrystal Biotech Announces Fourth Quarter and Full Year 2024 Financial and Operating ResultsFebruary 19 at 7:00 AM | globenewswire.comKrystal Biotech, Inc. (NASDAQ:KRYS) Sees Significant Decrease in Short InterestFebruary 19 at 3:50 AM | americanbankingnews.comKrystal Biotech Q4 2024 Earnings PreviewFebruary 18 at 6:29 PM | msn.comKrystal Biotech, Inc. (NASDAQ:KRYS) Short Interest Down 7.4% in JanuaryKrystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) was the recipient of a large decrease in short interest during the month of January. As of January 31st, there was short interest totalling 3,010,000 shares, a decrease of 7.4% from the January 15th total of 3,250,000 shares. Based on an average trading volume of 262,600 shares, the short-interest ratio is presently 11.5 days.February 17, 2025 | marketbeat.comKrystal Biotech (KRYS) Expected to Announce Earnings on MondayKrystal Biotech (NASDAQ:KRYS) will be releasing earnings before the market opens on Monday, February 24, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=663342)February 17, 2025 | marketbeat.comNAVEGA THERAPEUTICS APPOINTS NEW STRATEGIC ADVISORS TO THE BOARD OF ADVISORSFebruary 13, 2025 | finance.yahoo.com3,500 Shares in Krystal Biotech, Inc. (NASDAQ:KRYS) Bought by Entropy Technologies LPEntropy Technologies LP purchased a new stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 3,500 shares of the company's stock,February 13, 2025 | marketbeat.comKrystal Biotech (KRYS) Receives a Buy from Bank of America SecuritiesFebruary 11, 2025 | markets.businessinsider.comabrdn plc Has $8.94 Million Stake in Krystal Biotech, Inc. (NASDAQ:KRYS)abrdn plc grew its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 32.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 57,033 shares of the company's stock after purchasingFebruary 9, 2025 | marketbeat.comLife sciences get a spotlight in Shapiro budget proposalFebruary 6, 2025 | msn.comGov. Josh Shapiro's budget proposal includes $75M for innovation effortsFebruary 5, 2025 | bizjournals.comJennison Associates LLC Lowers Stake in Krystal Biotech, Inc. (NASDAQ:KRYS)Jennison Associates LLC lessened its stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 26.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 303,521 shares of the company's stock after selling 106,536 shares dFebruary 5, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Short Interest UpdateKrystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) saw a significant decrease in short interest during the month of January. As of January 15th, there was short interest totalling 3,370,000 shares, a decrease of 8.9% from the December 31st total of 3,700,000 shares. Based on an average daily volume of 247,300 shares, the days-to-cover ratio is currently 13.6 days.February 1, 2025 | marketbeat.comJanney Montgomery Scott LLC Acquires 15,545 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Janney Montgomery Scott LLC raised its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 42.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 52,592 shares of the company's stock after purchasing an additioJanuary 28, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Given Consensus Recommendation of "Buy" by BrokeragesKrystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) has received an average recommendation of "Buy" from the eight research firms that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation, six have assigned a buy recommeJanuary 26, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Short Interest Down 8.9% in DecemberKrystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) saw a large drop in short interest in December. As of December 31st, there was short interest totalling 3,370,000 shares, a drop of 8.9% from the December 15th total of 3,700,000 shares. Based on an average daily volume of 247,300 shares, the short-interest ratio is currently 13.6 days.January 18, 2025 | marketbeat.comKrystal Biotech appoints Saxena as CFOJanuary 14, 2025 | markets.businessinsider.comJeune Aesthetics Appoints Nishant Saxena as Chief Financial OfficerJanuary 14, 2025 | globenewswire.comJPMorgan Chase & Co. Has $23.28 Million Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS)JPMorgan Chase & Co. reduced its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 21.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 127,901 shares of the company's stock after selling 35January 9, 2025 | marketbeat.comPositive Report for Erasca (ERAS) from Bank of America SecuritiesJanuary 7, 2025 | markets.businessinsider.comKrystal Biotech, Inc. (KRYS) Stock ForecastsJanuary 1, 2025 | finance.yahoo.comKrystal Biotech, Inc. (NASDAQ:KRYS) Given Average Recommendation of "Buy" by AnalystsKrystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) has received a consensus recommendation of "Buy" from the eight brokerages that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation, six have issued a buy recommendatJanuary 1, 2025 | marketbeat.comKuehn Law Encourages Investors of Krystal Biotech, Inc. to Contact Law FirmDecember 28, 2024 | markets.businessinsider.comKrystal Biotech: Blockbuster Ambitions For Topical Gene TherapyDecember 27, 2024 | seekingalpha.comPrincipal Financial Group Inc. Sells 3,743 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Principal Financial Group Inc. trimmed its position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 3.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 119,726 shares of thDecember 26, 2024 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?December 23, 2024 | uk.finance.yahoo.comKrystal Biotech’s Promising Clinical Advancements and Strategic Outlook Support Buy RatingDecember 19, 2024 | markets.businessinsider.comGeode Capital Management LLC Boosts Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)Geode Capital Management LLC lifted its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 2.0% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 591,631 shares of the company's stDecember 19, 2024 | marketbeat.comKrystal Biotech early lung cancer data ‘promising,’ says H.C. WainwrightDecember 19, 2024 | markets.businessinsider.comHere's How Much $100 Invested In Krystal Biotech 5 Years Ago Would Be Worth TodayDecember 19, 2024 | benzinga.com Get Krystal Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter. Email Address KRYS Media Mentions By Week KRYS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KRYS News Sentiment▼0.750.60▲Average Medical News Sentiment KRYS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KRYS Articles This Week▼266▲KRYS Articles Average Week Get Krystal Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SMMT News GMAB News ITCI News VTRS News MRNA News RDY News PCVX News SRPT News QGEN News ASND News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KRYS) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Krystal Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Krystal Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KRYS Stock Alerts